Biological and RNA-based medicines are often sensitive to temperature variations, and for some, storage at extremely low temperatures is essential to maintain their stability, efficacy and safety. In accordance with ICH guidelines, some biological medicinal products require storage at -80°C, a particularly stringent condition that preserves the molecular properties of these complex products.
Storage at -80°C is generally required for biological products that are particularly unstable at higher temperatures, such as certain vaccines, enzymes or gene therapies. At this ultra-low temperature, protein degradation, aggregation and other undesirable chemical changes are minimised, ensuring that the drug retains its therapeutic properties until it is used.